Copyright
©The Author(s) 2022.
World J Clin Cases. Mar 16, 2022; 10(8): 2393-2403
Published online Mar 16, 2022. doi: 10.12998/wjcc.v10.i8.2393
Published online Mar 16, 2022. doi: 10.12998/wjcc.v10.i8.2393
Table 1 Demographic features
Pancreatic adenocarcinoma (n = 35) | Controls (n = 33) | P value | |
Age (yr) | 61.5 (46-79) | 48 (28-68) | < 0.001 |
Gender | |||
Male | 17 (48.6%) | 20 (60.6%) | 0.342 |
Female | 18 (51.4%) | 13 (39.4%) | |
rBF | 0.222 ± 0.089 | 1.000 ± 0.023 | < 0.001 |
rBV | 0.453 ± 0.193 | 0.993 ± 0.076 | < 0.001 |
rPE | 0.576 ± 0.278 | 1.003 ± 0.008 | < 0.001 |
rPermeability | 6.000 ± 1.395 | 0.949 ± 0.165 | < 0.001 |
rTTP | 1.917 ± 0.208 | 1.014 ± 0.039 | < 0.001 |
- Citation: Liu W, Yin B, Liang ZH, Yu Y, Lu N. Computed tomography perfusion imaging evaluation of angiogenesis in patients with pancreatic adenocarcinoma. World J Clin Cases 2022; 10(8): 2393-2403
- URL: https://www.wjgnet.com/2307-8960/full/v10/i8/2393.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i8.2393